vimarsana.com
Home
Live Updates
Sotera Health Reports Fourth-Quarter and Full-Year 2023 Results; Provides 2024 Outlook : vimarsana.com
Sotera Health Reports Fourth-Quarter and Full-Year 2023 Results; Provides 2024 Outlook
2023 net revenues increased 4.5% to $1.05 billion, compared to 20222023 net income of $51 million or $0.18 per diluted share2023 Adjusted EBITDA increased 4.3% to $528 million2023 Adjusted EPS ...
Related Keywords
Willowbrook
,
Illinois
,
United States
,
United Kingdom
,
Russia
,
Delaware
,
New Mexico
,
Canada
,
Georgia
,
Canadian
,
Jason Peterson
,
Kristin Gibbs
,
Michaelb Petras Jr
,
Sotera Health Company
,
Global Health
,
Company Nasdaq
,
Presentation Events Sotera Health
,
Sotera Health Net Leverage Ratio
,
Ethylene Oxide Sotera Health
,
Investor Relations Sotera Health
,
Keybanc Life Sciences Medtech Investor Forum
,
Sotera Health
,
Regulatory Compliance Associates Inc
,
United Kingdom Or European Union
,
Net Revenues
,
Health Company
,
Chief Executive Officer
,
Nelson Labs
,
Safeguarding Global
,
Net Leverage
,
Adjusted Net
,
Net Income
,
Net Leverage Ratio
,
Note Regarding Forward Looking Statements
,
Investor Relations
,
Healthcare Conference
,
Banc Life Sciences
,
Medtech Investor Forum
,
European Union
,
Adjusted Net Income
,
Net Debt
,
Safeguarding Global Health
,
Marketing Officer
,
Biosciences Labs
,
Medical Isotopes
,
Settlement Agreements
,
Defendant Subsidiaries
,
Settlement Term Sheet
,
Consolidated Statements
,
Ended December
,
Regulatory Compliance Associates
,
Markets
,
vimarsana.com © 2020. All Rights Reserved.